Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes of Shareholders' Equity

v3.22.1
Condensed Statements of Changes of Shareholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balances, Beginning at Dec. 31, 2020 $ 830 $ 57,905,164 $ (27,965,105) $ 29,940,889
Balances, Beginning (in shares) at Dec. 31, 2020 8,305,075      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense   24,825   24,825
Exercise of warrants $ 3 197,559   197,562
Exercise of warrants (in shares) 25,315      
Net loss     (3,056,033) (3,056,033)
Balances, Ending at Mar. 31, 2021 $ 833 58,127,548 (31,021,138) 27,107,243
Balances, Ending (in shares) at Mar. 31, 2021 8,330,390      
Balances, Beginning at Dec. 31, 2021 $ 833 58,425,604 (43,925,373) 14,501,064
Balances, Beginning (in shares) at Dec. 31, 2021 8,330,390      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation expense   131,906   131,906
Net loss     (3,960,308) (3,960,308)
Balances, Ending at Mar. 31, 2022 $ 833 $ 58,557,510 $ (47,885,681) $ 10,672,662
Balances, Ending (in shares) at Mar. 31, 2022 8,330,390